JoelMGoreMD
Cardiology • Worcester, MAAdult Congenital Heart Disease, Interventional Cardiology
Professor, Medicine, University Massachusetts Medical School
Dr. Gore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Department of Cardiovascular Medicine
Worcester, MA 01655Phone+1 774-441-6500Fax+1 774-441-7657
Education & Training
UMass Chan Medical SchoolFellowship, Cardiovascular Disease, 1980 - 1982- UMass Chan Medical SchoolResidency, Internal Medicine, 1977 - 1980
University of Calgary Faculty of MedicineClass of 1977
Certifications & Licensure
MA State Medical License 1978 - 2025
CT State Medical License 2004 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACP) American College of Physicians, 2007
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Thrombolysis in Myocardial Infarction (TIMI) Start of enrollment: 1983 Apr 01
Publications & Presentations
PubMed
- 17 citationsAssociation between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T. Yan, Wei Huang, Keith A.A. Fox, Joel M. Gore
American Heart Journal. 2010-11-01 - 402 citationsHemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis...Edwin G. Bovill, Michael L. Terrin, David C. Stump, Andrew D. Berke, Margaret Frederick
Annals of Internal Medicine. 1991-08-15 - 314 citationsTrends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myo...William J. Rogers, Paul D. Frederick, Edna Stoehr, John G. Canto, Joseph P. Ornato
American Heart Journal. 2008-12-01
Journal Articles
- Clinical Investigations Twenty-Five Year Trends (1986-2011) in Hospital Incidence and Case-Fatality Rates of Ventricular Tachycardia and Ventricular Fibrillation Compl...Catarina I Kiefe, Chad E Darling, Robert J Goldberg, Joel M Gore, ScienceDirect
- Hyperglycemia and Risk of Ventricular Tachycardia Among Patients Hospitalized with Acute Myocardial InfarctionCatarina I Kiefe, Joel M Gore, Robert J Goldberg, Chad E Darling, BioMed Central
Press Mentions
- Rivaroxaban Approved to Prevent CV Events in Patients with CAD or PADOctober 15th, 2018
Cardiogenic Shock Remains a Deadly Complication of Acute MI No Matter When It DevelopsJune 9th, 2017
Statin-Intolerant Patients Face Higher Risk for Recurrent MIMarch 14th, 2017- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
